The effects of cantharidin analogues on xanthine oxidase

Wei Tsauer, Jaung Geng Lin, Pen Yuan Lin, Feng Lin Hsu, Hsuch Ching Chiang

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Norcantharidin, the demethylated product of cantharidin has been used for the treatment of hepatoma, carcinomas of esophagus and gastric cardia, leukopenia and hepatitis. Since the enzyme xanthine oxidase is involved in the diseases mentioned above, and the reactive oxygen species produced by the enzyme induces DNA damage and oxidative damage of tissues, fourteen cantharidin analogues and cantharidimide derivatives were tested for their effects on xanthine oxidase. The results showed that these compounds displayed very weak inhibitory effects on xanthine oxidase. Contrary to expectation disodium cantharidate, Norcantharidin, dehydronorcantharidin, disodium dehydronorcantharidate, N-(2-pyridyl) cantharidimide, N-(3-pyridyl) cantharidimide and N-(4-pyridyl) cantharidimide showed a slight stimulating effect on xanthine oxidase at several concentrations.

Original languageEnglish
Pages (from-to)2095-2098
Number of pages4
JournalAnticancer Research
Volume17
Issue number3 C
Publication statusPublished - 1997

Fingerprint

Cantharidin
norcantharidin
Xanthine Oxidase
Cardia
Leukopenia
Enzymes
Hepatitis
Esophagus
DNA Damage
Hepatocellular Carcinoma
Reactive Oxygen Species
Stomach
Carcinoma

Keywords

  • Cantharidin and cantharidimide analogues
  • Toxic substances
  • Xanthine oxidase stimulants

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tsauer, W., Lin, J. G., Lin, P. Y., Hsu, F. L., & Chiang, H. C. (1997). The effects of cantharidin analogues on xanthine oxidase. Anticancer Research, 17(3 C), 2095-2098.

The effects of cantharidin analogues on xanthine oxidase. / Tsauer, Wei; Lin, Jaung Geng; Lin, Pen Yuan; Hsu, Feng Lin; Chiang, Hsuch Ching.

In: Anticancer Research, Vol. 17, No. 3 C, 1997, p. 2095-2098.

Research output: Contribution to journalArticle

Tsauer, W, Lin, JG, Lin, PY, Hsu, FL & Chiang, HC 1997, 'The effects of cantharidin analogues on xanthine oxidase', Anticancer Research, vol. 17, no. 3 C, pp. 2095-2098.
Tsauer W, Lin JG, Lin PY, Hsu FL, Chiang HC. The effects of cantharidin analogues on xanthine oxidase. Anticancer Research. 1997;17(3 C):2095-2098.
Tsauer, Wei ; Lin, Jaung Geng ; Lin, Pen Yuan ; Hsu, Feng Lin ; Chiang, Hsuch Ching. / The effects of cantharidin analogues on xanthine oxidase. In: Anticancer Research. 1997 ; Vol. 17, No. 3 C. pp. 2095-2098.
@article{fed7c4f04d2d42398ad0df030347e658,
title = "The effects of cantharidin analogues on xanthine oxidase",
abstract = "Norcantharidin, the demethylated product of cantharidin has been used for the treatment of hepatoma, carcinomas of esophagus and gastric cardia, leukopenia and hepatitis. Since the enzyme xanthine oxidase is involved in the diseases mentioned above, and the reactive oxygen species produced by the enzyme induces DNA damage and oxidative damage of tissues, fourteen cantharidin analogues and cantharidimide derivatives were tested for their effects on xanthine oxidase. The results showed that these compounds displayed very weak inhibitory effects on xanthine oxidase. Contrary to expectation disodium cantharidate, Norcantharidin, dehydronorcantharidin, disodium dehydronorcantharidate, N-(2-pyridyl) cantharidimide, N-(3-pyridyl) cantharidimide and N-(4-pyridyl) cantharidimide showed a slight stimulating effect on xanthine oxidase at several concentrations.",
keywords = "Cantharidin and cantharidimide analogues, Toxic substances, Xanthine oxidase stimulants",
author = "Wei Tsauer and Lin, {Jaung Geng} and Lin, {Pen Yuan} and Hsu, {Feng Lin} and Chiang, {Hsuch Ching}",
year = "1997",
language = "English",
volume = "17",
pages = "2095--2098",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 C",

}

TY - JOUR

T1 - The effects of cantharidin analogues on xanthine oxidase

AU - Tsauer, Wei

AU - Lin, Jaung Geng

AU - Lin, Pen Yuan

AU - Hsu, Feng Lin

AU - Chiang, Hsuch Ching

PY - 1997

Y1 - 1997

N2 - Norcantharidin, the demethylated product of cantharidin has been used for the treatment of hepatoma, carcinomas of esophagus and gastric cardia, leukopenia and hepatitis. Since the enzyme xanthine oxidase is involved in the diseases mentioned above, and the reactive oxygen species produced by the enzyme induces DNA damage and oxidative damage of tissues, fourteen cantharidin analogues and cantharidimide derivatives were tested for their effects on xanthine oxidase. The results showed that these compounds displayed very weak inhibitory effects on xanthine oxidase. Contrary to expectation disodium cantharidate, Norcantharidin, dehydronorcantharidin, disodium dehydronorcantharidate, N-(2-pyridyl) cantharidimide, N-(3-pyridyl) cantharidimide and N-(4-pyridyl) cantharidimide showed a slight stimulating effect on xanthine oxidase at several concentrations.

AB - Norcantharidin, the demethylated product of cantharidin has been used for the treatment of hepatoma, carcinomas of esophagus and gastric cardia, leukopenia and hepatitis. Since the enzyme xanthine oxidase is involved in the diseases mentioned above, and the reactive oxygen species produced by the enzyme induces DNA damage and oxidative damage of tissues, fourteen cantharidin analogues and cantharidimide derivatives were tested for their effects on xanthine oxidase. The results showed that these compounds displayed very weak inhibitory effects on xanthine oxidase. Contrary to expectation disodium cantharidate, Norcantharidin, dehydronorcantharidin, disodium dehydronorcantharidate, N-(2-pyridyl) cantharidimide, N-(3-pyridyl) cantharidimide and N-(4-pyridyl) cantharidimide showed a slight stimulating effect on xanthine oxidase at several concentrations.

KW - Cantharidin and cantharidimide analogues

KW - Toxic substances

KW - Xanthine oxidase stimulants

UR - http://www.scopus.com/inward/record.url?scp=0030878968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030878968&partnerID=8YFLogxK

M3 - Article

C2 - 9216670

AN - SCOPUS:0030878968

VL - 17

SP - 2095

EP - 2098

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 C

ER -